Literature DB >> 17211704

Liver biopsy: is the pain for real or is it only the fear of it?

Sinan Akay1, Zeki Karasu, Aysin Noyan, Semanur Pala, Ahmet Musoglu, Tankut Ilter, Yucel Batur.   

Abstract

Although percutaneous liver biopsy (PLB) has very low mortality and morbidity rates, it often is considered painful and frightening by the patients. This study was designed to grade the intensity of pain expected before the procedure and experienced during the procedure, and whether there is any correlation between pain and the emotional state of the patient. A total of 118 consecutive patients (aged 19-68 (mean, 44) years), who were undergoing PLB for the first time, were included in the study. Visual Analogue Scale (VAS) was used before the procedure, after the procedure to grade the degree of pain expected, and the degree of the pain experienced respectively. All the patients were evaluated by a questionnaire for their personality and emotional situation by using the Minnesota Multiphasic Personality Inventory Somatization Sub-scale (MMPI-SS). Mean VAS score for expected pain before the procedure was 60+/-20 and for the pain experienced during the procedure was 22+/-16 (P < 0.0001). Although the expected pain scores of female patients were significantly higher than males (66+/-22 vs. 55+/-17; P=0.003), there was no difference between female and male patients in the experienced pain scores. The procedure of PLB is expected to be more painful than it really is by the patients, especially by females. Calming the patients by informing them about the procedure and their diseases will probably diminish the expected pain.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17211704     DOI: 10.1007/s10620-006-9493-6

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  10 in total

1.  Pain experienced during percutaneous liver biopsy.

Authors:  L Castéra; I Nègre; K Samii; C Buffet
Journal:  Hepatology       Date:  1999-12       Impact factor: 17.425

2.  Can pre-emptive analgesia reduce pain experienced after liver biopsy?

Authors:  S Ferencz; R Batey
Journal:  Intern Med J       Date:  2002-03       Impact factor: 2.048

3.  Predictors of pain medication use after percutaneous liver biopsy.

Authors:  Thomas R Riley
Journal:  Dig Dis Sci       Date:  2002-10       Impact factor: 3.199

4.  Intrahepatic hematoma: a complication of percutaneous liver biopsy.

Authors:  D R Raines; R L Van Heertum; L F Johnson
Journal:  Gastroenterology       Date:  1974-08       Impact factor: 22.682

5.  Liver biopsy. Its safety and complications as seen at a liver transplant center.

Authors:  D H Van Thiel; J S Gavaler; H Wright; A Tzakis
Journal:  Transplantation       Date:  1993-05       Impact factor: 4.939

6.  Patient-administered nitrous oxide/oxygen inhalation provides safe and effective analgesia for percutaneous liver biopsy: a randomized placebo-controlled trial.

Authors:  L Castéra; I Nègre; K Samii; C Buffet
Journal:  Am J Gastroenterol       Date:  2001-05       Impact factor: 10.864

7.  Prevalence and characteristics of pain induced by percutaneous liver biopsy.

Authors:  E Eisenberg; M Konopniki; E Veitsman; R Kramskay; D Gaitini; Y Baruch
Journal:  Anesth Analg       Date:  2003-05       Impact factor: 5.108

Review 8.  Bile peritonitis after liver biopsy: nonsurgical management of a patient with an acute abdomen: a case report with review of the literature.

Authors:  R A Ruben; S Chopra
Journal:  Am J Gastroenterol       Date:  1987-03       Impact factor: 10.864

9.  Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies.

Authors:  F Piccinino; E Sagnelli; G Pasquale; G Giusti
Journal:  J Hepatol       Date:  1986       Impact factor: 25.083

10.  Liver biopsy complications monitored by ultrasound.

Authors:  E Hederström; L Forsberg; C H Florén; H Prytz
Journal:  J Hepatol       Date:  1989-01       Impact factor: 25.083

  10 in total
  6 in total

Review 1.  PRO: This Patient Should Have a Liver Biopsy.

Authors:  Akshata Moghe; Matthew Klinge; Naudia Jonassaint
Journal:  Clin Liver Dis (Hoboken)       Date:  2019-10-09

2.  An evaluation of the potential cost-effectiveness of non-invasive testing strategies in the diagnosis of significant liver fibrosis.

Authors:  Josh J Carlson; Kris V Kowdley; Sean D Sullivan; Scott D Ramsey; David L Veenstra
Journal:  J Gastroenterol Hepatol       Date:  2009-04-23       Impact factor: 4.029

3.  Safety and effectiveness of blind percutaneous liver biopsy: analysis of 1412 procedures.

Authors:  Aleksandra Szymczak; Krzysztof Simon; Malgorzata Inglot; Andrzej Gladysz
Journal:  Hepat Mon       Date:  2012-01-20       Impact factor: 0.660

4.  Wisteria floribunda agglutinin-positive Mac-2-binding protein in the prediction of disease severity in chronic hepatitis B patients.

Authors:  Ming-Lun Yeh; Chung-Feng Huang; Ching-I Huang; Chia-Yen Dai; I-Hung Lin; Po-Cheng Liang; Meng-Hsuan Hsieh; Zu-Yau Lin; Shinn-Chern Chen; Jee-Fu Huang; Jyh-Jou Chen; Ming-Lung Yu; Wan-Long Chuang
Journal:  PLoS One       Date:  2019-08-08       Impact factor: 3.240

5.  Integrated Hepatitis C Care for People Who Inject Drugs (Heplink): Protocol for a Feasibility Study in Primary Care.

Authors:  Geoff McCombe; Davina Swan; Eileen O'Connor; Gordana Avramovic; Peter Vickerman; Zoe Ward; Julian Surey; Juan Macías; John S Lambert; Walter Cullen
Journal:  JMIR Res Protoc       Date:  2018-06-04

6.  Incidence of Complications from Percutaneous Biopsy in Chronic Liver Disease: A Systematic Review and Meta-Analysis.

Authors:  Helena B Thomaides-Brears; Naim Alkhouri; Daniela Allende; Mukesh Harisinghani; Mazen Noureddin; Nancy S Reau; Marika French; Carlos Pantoja; Sofia Mouchti; Donna R H Cryer
Journal:  Dig Dis Sci       Date:  2021-06-15       Impact factor: 3.487

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.